A 54-year-old woman was examined following a positive fecal occult blood test performed within the screening program for colorectal cancer. The patient had no symptoms, no previous surgeries and her history was unremarkable. Physical examination and basic laboratory tests, including a blood count, were normal. A coloscopy was performed with a finding of a single polyp 5 mm in size in the sigmoid colon. The polyp was removed endoscopically and the histological examination revealed an adenoma. Subsequently, gastroduodenoscopy was performed and revealed a duodenal lesion very near the ampulla (Figure 1 ). The lesion was 18 mm in diameter with ulceration at the apex. No bleeding was visible. A biopsy sample was taken from the ulceration. No malignant structures were found. Endosonography was then performed and showed the homogeneous structure of the lesion originating from the submucous layer of duodenum. No lymphadenopathy was found (Figure 2 ). Magnetic resonance imaging revealed a mass in the second portion of the duodenum with no significant lymphadenopathy and no distant metastases.
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The diagnosis was not known before the treatment, but the lesions had the hallmark characteristics of a gastrointestinal stromal tumour. Endoscopic treatment of the lesion was considered but was not possible due to its location; thus, surgical resection was pursued. The abdominal cavity was approached through a right subcostal incision. A duodenotomy in the D2 was performed along with extirpation of the lesion. No complications occurred. The postoperative course was uneventful and the patient was discharged on postoperative day 11. A final histological examination showed findings typical of gangliocytic paraganglioma of the duodenum ( Figure 3) ; the resection line was free of the tumour.
The patient is currently being followed-up at our department and is complaint free, showing no signs of recurrence of the disease twoand-a-half years after the surgery.
Discussion
Gangliocytic paraganglioma was first described by Dahl in 1957 (1) . It is an extremely rare gastrointestinal tumour that is found predominantly in the second part of the duodenum, although some authors reported cases invading the proximal jejunum (2,3). There is a slight male predominance. The age at presentation ranges from 15 to 80 years, with an average of 54 years (4) .
The pathogenesis of this tumour is unclear. It has been suggested that the lesion is due to hamartomatous proliferation of endodermal cells at the ventral primordium of the pancreas and neuroectodermally derived ganglion and Schwann cells (3, 5) . This would help explain the high incidence of the tumour in the second portion of duodenum.
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Histologically, the tumour shows triphasic cellular differentiation with the presence of epitheloid neuroendocrine cells, spindle-shaped cells with Schwannian features and ganglion cells. The relative abundance of these cell types may vary (2, 5) . Precise diagnosis is verifiable by immunohistochemistry. In the described case, the neuroendocrine cells were positive for keratins, synaptophysin and chromogranin. Both mentioned neuroendocrine markers also labelled ganglion cells. Spindle cells showed strong expression of S-100 protein. CD117 was positive only focally in ganglion cells. The immunohistochemical profile of the reported tumour was consistent with other reports (2, 5) .
The most common presenting symptoms are abdominal pain, upper gastrointestinal bleeding and, less frequently, biliary obstruction or duodenal obstruction. Otherwise, these tumours are found incidentally during radiological imaging or during endoscopy performed for different purposes (2-4). Ultrasound shows a solid isoechogenic mass. On computed tomography scan and magnetic resonance imaging, these tumours are solid and homogenous in appearance (2) . Its endoscopic picture does not differ from other submucosal tumours and, therefore, endosonography with biopsy is usually advocated (2). However, accurate preoperative diagnosis is often difficult.
Small tumours are managed with local excision performed endoscopically or surgically by means of duodenotomy. Larger tumours with lymph node involvement require pancreaticoduodenectomy with standard lymph node dissection (2, 3) . No adjuvant treatment strategy has been determined due to the rarity of the disease (3).
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